Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • COX
    (1)
  • Prostaglandin Receptor
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Immune System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

rebamipide-d4

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
  • Isotope Products
    1
    TargetMol | Isotope_Products
Other Forms of Products
  • Rebamipide
    Proamipide, OPC12759
    T156290098-04-7
    Rebamipide (OPC12759) is a quinolinone derivative with anti-ulcer and anti-inflammatory activities. Rebamipide induces cyclooxygenase 2 (COX2) synthesis which results in an increase in endogenous prostaglandin synthesis in the gastric mucosa. This agent also inhibits H. pylori-induced production of tumor necrosis factor (TNF) alpha and subsequent inflammation of the gastric mucosa. In addition, rebamipide scavenges oxygen-derived free radicals that potentially cause mucosal injury, and stimulates prostaglandin EP4 receptor gene expression followed by mucous secretion, thereby enhancing the gastric mucosal defense.
    • $33
    In Stock
    Size
    QTY